title: [Trial production of tabellae papaini compositus].
abstract: This article reports on the technological standards for trial production of Tabellae Papaini Compositus, including the prescription, preparation, quality control, indications and usage. The clinical observation results show that the total effect rate comes to 94.06 percent for some inflammatory diseases.
authors.forename: Y J
authors.initials: YJ
authors.lastname: Liang
mesh_terms: D004338:Drug Combinations; D050723:Fractures, Bone / Q000188:drug therapy; D006801:Humans; D010149:Postoperative Pain / Q000188:drug therapy; D010206:Papain / Q000032:analysis / Q000627:therapeutic use; D013607:Tablets; D013678:Technology, Pharmaceutical
chemical_list: D004338:Drug Combinations; D013607:Tablets; D010206:Papain